Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MirReMed Edsviken AB
AB
Active
Org 5593218240
Edsviksvägen 83, 182 35
Danderyd
Rental and operating of own or leased real estate
· NACE 6820
Est. 2021
0 employees
Watchlist
Share
Sweden
/
Companies
/
Rental and operating of own or leased real estate
/
MirReMed Edsviken AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
1M
2022
1M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
265
1 180
1 418
1 501
1 564
Staff expenses
—
—
—
—
—
EBITDA
118
878
1 101
1 158
1 155
Depreciation & amort.
−74
−293
−356
−362
−377
EBIT
44
584
745
795
778
Net financials
−78
−542
−780
−779
−770
Profit before tax
−34
42
−35
16
8
Tax
−0
−2
—
—
—
Net profit
−34
40
−35
16
8
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
26 002
29 769
29 165
28 851
29 119
Equity
−9
31
−4
13
20
Long-term debt
25 447
28 832
28 613
28 405
28 658
Short-term debt
563
906
556
434
441
Total debt
26 010
29 738
29 169
28 839
29 099
Financial ratios
5-year trend
EBITDA margin
73.8%
This company
15.8%
Market median
+367% vs market
2021
2025
Equity ratio
0.1%
This company
38.2%
Market median
-100% vs market
2021
2025
Return on equity
37.6%
This company
18.4%
Market median
+104% vs market
2021
2025
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
2021
2025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2021
2025
Debt / equity
1441.75×
This company
0.62×
Market median
-232440% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31
View
PDF
More on MirReMed Edsviken AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network